98214461 - PRL

Information

• Trademark
• 98214461

• Source

• Serial Number

  98214461

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 09, 2023
  8 months ago

• Transaction Date

  April 30, 2024
  2 months ago

• Status Date

  April 30, 2024
  2 months ago

• Location Date

  April 30, 2024
  2 months ago

• Status Code

  641

• Current Location

  TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  SEGAL, MOLLY DANIELA

• Attorney Docket Number

  131399-0003

  Attorney Name

  Kristin H. Altoff

  Law Office Assigned Location Code

  L50

• Owners

  • ReNAgade Therapeutics Management Inc.

Case File Statements

• GS0051: Pharmaceutical preparations, lipids, lipid nanoparticles, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds/agents for medical use; pharmaceutical preparations and therapeutic agents, namely, for RNA, gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation
• GS0011: Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticles, lipid formulations, nucleic acids and modified nucleic acids, including short RNAs and messenger RNAs; nucleic acid sequences for scientific purposes, research purposes, and laboratory purposes other than medical and veterinary purposes
• GS0421: Research and development in the field of technology and engineering, lipids, lipid nanoparticles, lipid formulations and RNAs for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of lipids, lipid nanoparticles, lipid formulations, RNAs, namely, developing molecular and cellular biology reagents, techniques, and assays for use in pharmaceutical and biomedical industry

Case File Event Statements

• 4/26/2024 - 2 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 4/30/2024 - 2 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/30/2024 - 2 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/30/2024 - 2 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 10/12/2023 - 8 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/15/2023 - 8 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS